NCT03399526 - 1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 11, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Psoriasis

Interventions

DRUG

Mapracorat (ZK 245186, BAY 86-5319)

0.1% (1 mg/g) of the active ingredient mapracorat plus excipients as ointment

DRUG

Prednicarbate 0.25% ointment

0.25% (2.5 mg/g) of the active ingredient prednicarbate as ointment

DRUG

Clobetasol 0.05% ointment

0.05% (0.5 mg/g) of the active ingredient clobetasol as ointment

DRUG

Calcipotriene 0.005% ointment

0.005% (0.05 mg/g) of the active ingredient calcipotriene as ointment

DRUG

Calcipotriene 0.005%/Betamethasone dipropionate 0.05% ointment

0.005% (0.05 mg/g) of the active ingredient calcipotriene/0.05% (0.5 mg/g) of the active ingredient betamethasone dipropionate as ointment

Trial Locations (1)

Hamburg